MX2020006592A - Modificacion dirigida inducible de acidos nucleicos por luz e informacion genetica. - Google Patents

Modificacion dirigida inducible de acidos nucleicos por luz e informacion genetica.

Info

Publication number
MX2020006592A
MX2020006592A MX2020006592A MX2020006592A MX2020006592A MX 2020006592 A MX2020006592 A MX 2020006592A MX 2020006592 A MX2020006592 A MX 2020006592A MX 2020006592 A MX2020006592 A MX 2020006592A MX 2020006592 A MX2020006592 A MX 2020006592A
Authority
MX
Mexico
Prior art keywords
light
nucleic acids
genetic information
targeted modification
inducible
Prior art date
Application number
MX2020006592A
Other languages
English (en)
Inventor
Stefan Schillberg
Gerda Nölke
Fiore Stefano Di
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Publication of MX2020006592A publication Critical patent/MX2020006592A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/30—Characterised by physical treatment
    • C12Q2523/313—Irradiation, e.g. UV irradiation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La tecnología proporcionada en este documento se refiere a los métodos para la modificación de un ácido nucleico objetivo in vitro, ex vivo o in vivo en el genoma de una célula mediante el uso de un complejo preensamblado que comprende un ácido nucleico y una nanoagrupación metálica y exponiendo el complejo unido a un ácido nucleico 5 objetivo a la radiación electromagnética.
MX2020006592A 2017-12-20 2018-12-19 Modificacion dirigida inducible de acidos nucleicos por luz e informacion genetica. MX2020006592A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17208812.2A EP3502251A1 (en) 2017-12-20 2017-12-20 Light-inducible target modification of nucleic acids and genetic information
PCT/EP2018/085860 WO2019121928A1 (en) 2017-12-20 2018-12-19 Light-inducible targeted modification of nucleic acids and genetic information

Publications (1)

Publication Number Publication Date
MX2020006592A true MX2020006592A (es) 2020-09-09

Family

ID=60888192

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006592A MX2020006592A (es) 2017-12-20 2018-12-19 Modificacion dirigida inducible de acidos nucleicos por luz e informacion genetica.

Country Status (12)

Country Link
US (1) US11718843B2 (es)
EP (2) EP3502251A1 (es)
JP (1) JP2021508450A (es)
KR (1) KR20200100145A (es)
CN (1) CN111511913A (es)
BR (1) BR112020011937A2 (es)
CA (1) CA3084697A1 (es)
CL (1) CL2020001651A1 (es)
MX (1) MX2020006592A (es)
RU (1) RU2020123685A (es)
SG (1) SG11202005769RA (es)
WO (1) WO2019121928A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114317684B (zh) * 2021-12-15 2023-12-26 南京大学 一种基于tna分子的细胞内镁离子成像的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7263445B2 (en) * 2000-12-13 2007-08-28 Karsten Koenig Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular DNA
US8476014B2 (en) 2010-02-19 2013-07-02 Los Alamos National Security, Llc Probe and method for DNA detection
US9499866B2 (en) 2013-05-22 2016-11-22 Los Alamos National Security, Llc Compositions and methods for detecting single nucleotide polymorphisms
CN106018366B (zh) * 2016-05-09 2019-05-28 福建中医药大学 一种荧光dna-银纳米簇及其制备方法以及应用
CN106399367A (zh) * 2016-08-31 2017-02-15 深圳市卫光生物制品股份有限公司 提高crispr介导的同源重组效率的方法

Also Published As

Publication number Publication date
WO2019121928A1 (en) 2019-06-27
RU2020123685A3 (es) 2022-02-04
BR112020011937A2 (pt) 2020-11-24
SG11202005769RA (en) 2020-07-29
KR20200100145A (ko) 2020-08-25
RU2020123685A (ru) 2022-01-20
CA3084697A1 (en) 2019-06-27
EP3728584A1 (en) 2020-10-28
CN111511913A (zh) 2020-08-07
CL2020001651A1 (es) 2020-12-28
EP3502251A1 (en) 2019-06-26
US20210214710A1 (en) 2021-07-15
JP2021508450A (ja) 2021-03-11
US11718843B2 (en) 2023-08-08

Similar Documents

Publication Publication Date Title
JOP20210231A1 (ar) مركبات ترابطية مستهدفة كمركبات علاجية
SG10201809564YA (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
EA201991369A1 (ru) Модифицированные направляющие рнк
BR112016013400A2 (pt) métodos para modificar um genoma e para produzir um camundongo
TN2014000493A1 (en) Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
WO2014186585A3 (en) Methods and compositions for treatment of a genetic condition
MY174390A (en) Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
CA2884084C (en) Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
NZ705745A (en) Fad3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
MX2020003339A (es) Arn guía de cpf1 modificado.
EP2171078A4 (en) ENABLING THE USE OF LONG DSRNA FOR GENE TARGETING IN MAMMALIAN CELLS AND OTHER SELECTED ANIMAL CELLS
MX2013000315A (es) Molecula de acido nucleico de cadena simple para el control de la expresion de genes.
WO2014066915A3 (en) Methods and compositions to produce ss-rnai activity with enhanced potency
UA105073C2 (uk) Антитіло проти фракталкіну, композиція і спосіб для лікування запальних порушень
MX2015016371A (es) Métodos y composiciones para ensamblaje templado de heterocompuestos específicos de acido nucleico.
MX2020010802A (es) Moleculas inhibidoras de acidos nucleicos de caracter bicatenario modificadas con nucleotidos que aumentan la tm.
EA032977B1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения
CA2876165C (en) Particle-nucleic acid conjugates and therapeutic uses related thereto
MX2020006592A (es) Modificacion dirigida inducible de acidos nucleicos por luz e informacion genetica.
WO2011103011A3 (en) Gene fusion targeted therapy
WO2010101994A3 (en) Gene fusion targeted therapy
WO2011154611A3 (en) A method for enhanced protein synthesis
EA202090892A1 (ru) МОДИФИЦИРОВАННАЯ НАПРАВЛЯЮЩАЯ РНК Cpf1
Shkabriy THE OPPORTUNITIES FOR TRADING OPERATIONS INTERNAL AUDIT PLANNING PROCESS INTENSIFICATION
Tooze et al. Molecular Mechanisms of Autophagy-Part B